← Back to headlines





Analysts Project Significant Upside for Sellas Life Sciences Stock
Financial analysts highlight strong growth potential for biotech firm Sellas Life Sciences, forecasting a possible 150% increase in its share value based on current pipeline developments.
2 Sept, 19:30 — 2 Sept, 19:30
Related Stories

Revolut Secures Conditional U.S. National Bank Charter
25m ago

Ryanair Cuts Winter Flight Capacity and Warns of Fare Increases Amid High Fuel Costs
33m ago
Canada’s Trade Surplus Narrows in July Amid Falling Exports
39m ago

Snowflake Stock Soars After AI-Driven Revenue Growth Powers Blowout Quarter
51m ago